Developed with pharmacists for pharmacists, the GSX supports efficient process development, reliable scale-up and robust production of challenging APIs. Its flexible air distribution, application-specific particle collection and full GMP design enable targeted particle engineering, enhanced solubility and bioavailability and efficient downstream processing. Designed for highly potent products up to OEB 5, the GSX also features a clear scale-up concept and, as standard, a Part 11-compliant production-scale SCADA system.

The integration of the GSX.Lab adds spray drying to the MultiLab®, offering customers an even broader range of processes and greater application flexibility.

From spray drying to dry granulation – An integrated process chain for poorly soluble APIs

Customers benefit from Glatt’s ability to integrate spray drying and downstream roller compaction into one coordinated process concept. Through its partnership with Swiss machine manufacturer Faytec, Glatt can incorporate dry granulation as the next processing step after spray drying, supporting efficient process development, reliable scale-up and robust manufacturing of advanced formulations.

At Glatt, customers benefit with Glatt Pharmaceutical Services providing formulation development, process optimization, scale-up, clinical trial supply services and commercial production: This enables flexible make-or-buy options range from technology transfer to contract development and outsourced manufacturing.

Schedule your appointment with our CDMO experts now.